National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/26/2021 release of VAERS data:

Found 1,797 cases where Vaccine is COVID19 and Symptom is Guillain-Barre syndrome

Government Disclaimer on use of this data



Case Details

This is page 4 out of 180

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13   next


VAERS ID: 1030119 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: North Carolina  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-02-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021112808

Write-up: Guillain-Barre Syndrome; This is a spontaneous report from a non-contactable physician. A 64-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. It was reported that, male 64 admitted at (Institution name) on 30Jan2021 with Guillain-Barre Syndrome after receiving Pfizer COVID vaccine. Event took place after use of product. It was shared on 30Jan2021 with physician by a doctor in town. They were in the doctors lounge this morning discussing the case. This was all of the information physician have. The event was considered as serious (hospitalization) by the physician. The outcome of the event was unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.; Sender''s Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported event of Guillain-Barre Syndrome due to temporal relationship. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.


VAERS ID: 1033202 (history)  
Form: Version 2.0  
Age: 71.0  
Sex: Male  
Location: California  
Vaccinated:2021-01-19
Onset:2021-01-20
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: CSF protein increased, Guillain-Barre syndrome, Magnetic resonance imaging brain, Spinal X-ray
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 27 days
   Extended hospital stay? No
Previous Vaccinations: Pneumococcal Vaccine
Other Medications: ? clonazePAM (KLONOPIN) 0.5 mg Oral Tab Take 1 and one-half tablets by mouth daily at bedtime ? Mirtazapine (REMERON) 15 mg Oral Tab Take 1 tablet by mouth daily at bedtime ? metFORMIN (GLUCOPHAGE XR) 500 mg Oral 24hr SR Tab Take 2 tablets
Current Illness: STROKE. 2008 ? ATHEROSCLEROSIS OF AORTA cxr 8/11 ? BIPOLAR 1 DISORDER, UNSPECIFIED EPISODE ? ? CAD (CORONARY ARTERY DISEASE) ? ? DM 2 ? ? GERD (GASTROESOPHAGEAL REFLUX DISEASE) ? ? HYPOTHYROIDISM ? ? PPD POSITIVE. s/p cataract surgery s/p tonsillectomy
Preexisting Conditions: As above, CAD, prior stroke (no deficits), bipolar disorder, and DM
Allergies: Pneumococcal Vaccine Quinine NSAIDs
Diagnostic Lab Data: MRI brain and c-spine, both unrevealing for acute changes. CSF analysis showed normal parameters except elevated CSF protein.
CDC Split Type:

Write-up: Patient was hospitalized for Guillain-Barre syndrome


VAERS ID: 1033614 (history)  
Form: Version 2.0  
Age: 42.0  
Sex: Female  
Location: Florida  
Vaccinated:2021-01-15
Onset:2021-01-22
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-02-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 039K20A / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Autoimmune demyelinating disease, CSF protein increased, CSF white blood cell count negative, Cauda equina syndrome, Computerised tomogram head normal, Gait disturbance, Guillain-Barre syndrome, Injection site erythema, Injection site reaction, Injection site warmth, Lumbar puncture abnormal, Magnetic resonance imaging brain normal, Magnetic resonance imaging spinal abnormal, Paraesthesia, Peripheral motor neuropathy, Peripheral sensory neuropathy, Plasmapheresis, Protein total increased, Pruritus, White blood cell count decreased
SMQs:, Anaphylactic reaction (broad), Haematopoietic leukopenia (narrow), Peripheral neuropathy (narrow), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Parkinson-like events (broad), Guillain-Barre syndrome (narrow), Extravasation events (injections, infusions and implants) (broad), Optic nerve disorders (broad), Demyelination (narrow), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Sjogren''s syndrome, hypothyroidism, anemia
Allergies: Latex, tramadol
Diagnostic Lab Data: CT head without contrast 2/10/21: no acute intracranial abn MRI L-spine 2/12/21: Mild diffuse enhancement of the cauda equina nerve roots, which may be seen with Gillian Barre syndro MRI brain demyelinating disease 2/12/21: No acute intracranial abnormality. No abnormal parenchymal enhancement. No evidence of acute/subacute ischemia LP 2/11/21: cytoalbuminologic dissociation (75 protein, 3 WBC)
CDC Split Type:

Write-up: Patient received first Moderna vaccine on 1/15/2021. Delayed injection site reaction which was warm and erythematous 1 week after vaccination on left arm for which was seen by PCP and prescribed Bactrim for 10 days. On 2/3/21 patient experienced itchiness in hands and feet with pins and needles sensation. Seen by PCP on 2/4/21 and was started on Medrol Dose Pack for pruritis and paresthesias. 2/10/21 presented to ED with progressive sensory motor polyneuropathy and early gait dysfunction. Patient started plasmapharesis treatment for suspected Guillan-Barre Syndrome on 2/11/2021.


VAERS ID: 1040844 (history)  
Form: Version 2.0  
Age: 71.0  
Sex: Male  
Location: Ohio  
Vaccinated:2021-01-16
Onset:2021-01-30
   Days after vaccination:14
Submitted: 0000-00-00
Entered: 2021-02-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL3249 / 1 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Asthenia, Blood potassium decreased, Blood pressure fluctuation, Blood sodium decreased, Blood test normal, CSF protein increased, Chest pain, Computerised tomogram normal, Dysstasia, Echocardiogram normal, Electrocardiogram normal, Electroencephalogram normal, Fine motor skill dysfunction, Gait inability, Guillain-Barre syndrome, Hypoaesthesia, Injection site pain, Lumbar puncture, Magnetic resonance imaging normal, Muscular weakness, Paraesthesia
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dystonia (broad), Parkinson-like events (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Extravasation events (injections, infusions and implants) (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Hyponatraemia/SIADH (narrow), Hypertension (broad), Cardiomyopathy (broad), Demyelination (narrow), Chronic kidney disease (broad), Hypokalaemia (narrow), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 11 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Lisinopril 40 mg tablet Hydrochlorothiazide 25 mg tablet asprin 81 mg Glucosamine JCL 1500 with MSM 600+D3 Calcium a
Current Illness: None
Preexisting Conditions: Elevated BP - Nothing else
Allergies: None
Diagnostic Lab Data: 1/30-2/2 - EKG, Between 2/2 - 2/12 - Echocardiogram, 2 C Scans, MRI, multiple Blood tests - all were negative but his Sodium and Potassium level were very low, particularly the sodium level. Given IV treatment for that. 2/15 - EEG - Negative, Spinal Tap - Protein level I believe was 113. Diagnosed Guillain Barre Syndrome -
CDC Split Type:

Write-up: 1/30/2021 Began with spiking BP and extreme pain in right shoulder - taken to ER. Given pain med, BP came down and sent home. 2/2/2021 - Spiking BP and chest pain, numbness and tingling in hands and feet. - taken to Medical Center. Admitted. Series of heart and brain assessments done. Each day he got weaker until he could no longer stand, walk, arm and hand strength depleted and dexterity issues. Spinal Tap on 2/8/2021 revealed Guillain Barre Syndrome 2/12 Admitted to Rehabilitation Center, 2/15 at Hospital plummeting BP, 2/18 return to Rehabilitation Center


VAERS ID: 1041155 (history)  
Form: Version 2.0  
Age: 70.0  
Sex: Female  
Location: Minnesota  
Vaccinated:2021-02-11
Onset:2021-02-12
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 LA / IM

Administered by: Other       Purchased by: ?
Symptoms: Ataxia, Blood electrolytes, CSF test, Full blood count, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Magnetic resonance imaging brain, Magnetic resonance imaging spinal, Nausea, Pain, Paraplegia
SMQs:, Acute pancreatitis (broad), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Demyelination (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ATORVASTSTIN 10 MG q DAY
Current Illness: NONE
Preexisting Conditions: NONE
Allergies: NONE
Diagnostic Lab Data: CSF MRI BRAIN MRI SPINE CBC/ELECTROLYTES
CDC Split Type:

Write-up: ACUTE LEFT SIDED COSTOPHRENIC PAIN AND NAUSEA WITH RAPID DEVELOPMENT OF BILATERAL NUMBNESS WITH ATAXIA STARTING AT FEET RISING TO GROIN IMMEDIATELY. NUMBNESS AND PARAPLEGIA PERSISTED AND AROSE TO RIBS WITHIN 12 HOURS TWO ER VISITS. HOSPITALIZED AND MONITORED FOR FOUR DAYS DX: ACUTE GUILLAIN-BARRE SYNDROME per NEUROLOGY Received 4 infusions of IViG. 1 infusion per day X 4 days.


VAERS ID: 1041319 (history)  
Form: Version 2.0  
Age: 86.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2021-02-04
Onset:2021-02-08
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-02-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH DL3246 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Immunoglobulin therapy, Lumbar puncture, Muscular weakness
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: 2/11/21 Lumbar Puncture
CDC Split Type:

Write-up: 2/8/21 pt noted to have BLE weakness. 2/10/21 pt admitted to Hospital and diagnosed with Guillain-Barre Syndrome. She received 5 days of IVIG treatment. 2/15/21 she was discharged from acute care and admitted to inpatient rehab where she is still admitted at this time.


VAERS ID: 1041542 (history)  
Form: Version 2.0  
Age: 37.0  
Sex: Female  
Location: Kentucky  
Vaccinated:2021-01-29
Onset:2021-02-06
   Days after vaccination:8
Submitted: 0000-00-00
Entered: 2021-02-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 2 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: unknown
CDC Split Type:

Write-up: Patient received 2nd dose on 1/29/21. Was treated for symptoms of Guillian Barre syndrome requiring inpatient rehabilitation.


VAERS ID: 1042915 (history)  
Form: Version 2.0  
Age: 52.0  
Sex: Male  
Location: Florida  
Vaccinated:2021-01-25
Onset:2021-02-10
   Days after vaccination:16
Submitted: 0000-00-00
Entered: 2021-02-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 025J20A / 1 - / IM
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 028L26A / 2 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Autoimmune hepatitis, Blood test, Guillain-Barre syndrome, Immunoglobulin therapy, Magnetic resonance imaging
SMQs:, Hepatitis, non-infectious (narrow), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Valtrex 500 BID, Benicar 40 QD, 81 ASAS QD, Vitamin Ds 15000U daily
Current Illness: None
Preexisting Conditions: HTN, alpha one antitrypsin carrier (MS phenotype)
Allergies: PCN
Diagnostic Lab Data: LP X 2, Contrasted ad un-contrasted MRI holo spine X 2, multiple blood tests
CDC Split Type:

Write-up: Guillain-Barr? syndrome. So far hospitalized =X 7 days, on day 3 of IV IG with ICC line, then planned 3 days of high dose soleumedrol, then plasmapheresis Auto-immune hepatitis


VAERS ID: 1043358 (history)  
Form: Version 2.0  
Age: 72.0  
Sex: Female  
Location: D.C.  
Vaccinated:2021-02-14
Onset:2021-02-15
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK UN / SYR

Administered by: Private       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Lumbar puncture, Magnetic resonance imaging spinal
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Multivitamin
Current Illness: Viral conjunctivitis Macular papular rash cause unknown
Preexisting Conditions: Breast Cancer Hypothyroidism
Allergies:
Diagnostic Lab Data: MRI Spine Lumbar puncture
CDC Split Type:

Write-up: Guillain Barre Syndrome


VAERS ID: 1049819 (history)  
Form: Version 2.0  
Age: 56.0  
Sex: Male  
Location: California  
Vaccinated:2021-01-20
Onset:2021-01-21
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 029L20A / 1 LA / -

Administered by: Other       Purchased by: ?
Symptoms: CSF protein increased, Gait inability, Guillain-Barre syndrome, Immunoglobulin therapy, Magnetic resonance imaging spinal abnormal, Muscular weakness, Vertebral foraminal stenosis, Vitamin B12 deficiency
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Dystonia (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: acetaminophen 325 mg Tab (Tylenol) 650 mg 2 tab Oral TID PRN: pain capsaicin 0.025% Cream 60 gm (capsaicin 0.025% topical cream) 1 app Topical Daily cholecalciferol 2,000 unit Cap (Vitamin D3) 2,000 unit 1 cap Oral Daily clotrimaz
Current Illness: DM HTN Chronic kidney disease
Preexisting Conditions: DM HTN Chronic kidney disease
Allergies: Penicillin
Diagnostic Lab Data: CSF analysis, showed elevation of serum protein MRI of Lumbar spine showed mild to moderate neural foraminal stenosis. Vitamin B12 was also reported deficient.
CDC Split Type:

Write-up: Patient developed lower extremity weakness, the weakness progressed and after few days he was not able to walk even with help of crutches. Guillain barre syndrome was suspected. He was sent to hospital. Lumbar puncture was performed on him showed elevation of CSF protein. He received IVIG and his weakness improved. He also received Vitamin B12 injection due to Vitamin B12 deficiency


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=4&SYMPTOMS=Guillain-Barre_syndrome_%2810018767%29&VAX=COVID19


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166